Skip to main content

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Invesco Ltd. DISH DISH Network Corp. 13G/A 0.3% 2y
Invesco Ltd. UNVR Univar Solutions Inc. 13G/A 0% 2y
Invesco Ltd. PI Impinj Inc 13G/A 1.9% 2y
Invesco Ltd. DXC DXC Technology Co 13G/A 4.9% 2y
COWEN AND COMPANY, LLC ICNC Iconic Sports Acquisition Corp. 13G/A 0% 2y
Invesco Ltd. ZEUS Olympic Steel, Inc. 13G/A 2.8% 2y
COWEN AND COMPANY, LLC FSNB Fusion Acquisition Corp. II 13G/A 0% 2y
Invesco Ltd. SABR Sabre Corp 13G/A 0.4% 2y
COWEN AND COMPANY, LLC AILE iLearningEngines, Inc. Common Stock 13G/A 4.95% 2y
Invesco Ltd. TDS Telephone & Data Systems Inc 13G/A 2% 2y
Invesco Ltd. MOMO Hello Group Inc. 13G/A 4.9% 2y
GOLDMAN SACHS GROUP INC CVNA Carvana Co. 13G/A 1.2% 2y
Invesco Ltd. MPAA Motorcar Parts Of America Inc 13G/A 0.2% 2y
COWEN AND COMPANY, LLC DSAQ Direct Selling Acquisition Corp. 13G/A 3.57% 2y
Invesco Ltd. NXH Neighborhood Intelligence, Inc. 13G/A 1% 2y
Invesco Ltd. USFD US Foods Holding Corp. 13G/A 3.9% 2y
Invesco Ltd. ROAD Construction Partners, Inc. 13G/A 3.1% 2y
Invesco Ltd. ARCO Arcos Dorados Holdings Inc. 13G/A 4.6% 2y
Santa Venerina Inv. & Arbitrage Ltd. MLKMF Waldencast plc 13G 9.9% 2y
Neil S. Subin GULTU Gulf Coast Ultra Deep Royalty Trust 13G/A 14.3% 2y
BlackRock Inc. DLTR Dollar Tree, Inc. 13G/A 7.2% 2y
BlackRock Inc. VZ Verizon Communications Inc 13G/A 7.9% 2y
BlackRock Inc. JPM Jpmorgan Chase & Co 13G/A 6.6% 2y
BAILLIE GIFFORD & CO VRM Vroom, Inc. 13G/A 0% 2y
Hui Li UCL uCloudlink Group Inc. 13G/A 7.3% 2y
Starboard Value LP GDDY GoDaddy Inc. 13D/A 6.2% 2y
Point72 Asset Management, L.P. ITRMF Iterum Therapeutics plc 13G 6.3% 2y
GAMCO INVESTORS, INC. ET AL EML Eastern Co 13D/A 8.32% 2y
Point72 Asset Management, L.P. ARQT Arcutis Biotherapeutics, Inc. 13G 5.2% 2y
Fairmount Funds Management LLC APGE Apogee Therapeutics, Inc. 13D/A 9.99% 2y
Saba Capital Management, L.P. BMEZ BlackRock Health Sciences Term Trust 13D/A 17.01% 2y
GILEAD SCIENCES, INC. RCUS Arcus Biosciences, Inc. 13D/A 35% 2y
5AM Partners VII, LLC SKYE Skye Bioscience, Inc. 13D/A 44.2% 2y
Redmile Group, LLC SNCE Science 37 Holdings, Inc. Common Stock 13D/A 16.5% 2y
Cano Health, Inc. MSPR MSP Recovery, Inc. 13D/A 40% 2y
Tenshi Healthcare Pte. Ltd. OTLK Outlook Therapeutics, Inc. 13D/A 6.4% 2y
ADAR1 Partners, LP CLRB Cellectar Biosciences, Inc. 13G 6.21% 2y
LB Partners LLC WOW WideOpenWest, Inc. Common Stock 13G 5.6% 2y
Stonepine Capital Management, LLC CALC CalciMedica, Inc. 13G 9.7% 2y
FIFTHDELTA Ltd FSR Fisker Inc. 13G/A 3.72% 2y
Harraden Circle Investments, LLC GCTS GCT Semiconductor Holding, Inc. 13G 3.45% 2y
BlackRock Inc. RDVT Red Violet, Inc. 13G 5.3% 2y
BlackRock Inc. ROKU Roku, Inc 13G 5.6% 2y
BlackRock Inc. FRPT Freshpet, Inc. 13G 5.1% 2y
Migdal Insurance & Financial Holdings Ltd. CAMT Camtek Ltd 13G 4.3% 2y
Migdal Insurance & Financial Holdings Ltd. SLGL Sol-Gel Technologies Ltd. 13G 5.31% 2y
BlackRock Inc. BWFG Bankwell Financial Group, Inc. 13G 5.2% 2y
NORTH SHORE TRUST & SAVINGS EMPLOYEE STOCK OWNERSHIP PLAN TRUST NSTS NSTS Bancorp, Inc. 13G/A 8.1% 2y
BlackRock Inc. PSTX Poseida Therapeutics, Inc. Common Stock 13G 5.3% 2y
Harraden Circle Investments, LLC CNDA Concord Acquisition Corp II 13G/A 0% 2y